Introduction: The treatment for stress urinary incontinence (SUI) includes conservative and surgical management. Apart from advantages and disadvantages, vaginal laser is considered as an alternative therapy for SUI. This study aims to review the effectiveness of laser therapy either erbium-doped yttrium–aluminum–garnet (Er:YAG) or carbon dioxide (CO2) laser for female SUI.
Methods: We used preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines for the appraisal. Eligibility criteria was SUI women undergoing Er:YAG or CO2 lasers compared with conservative or surgical management concerning the outcome such as improvement of SUI severity, sexual function, and quality of life.
Results: Three studies consisting of one randomized controlled trial (RCT) and two prospective studies were included and assessed for risk of bias using the revised Cochrane risk-of-bias tool (RoB 2) and the risk of bias in nonrandomized studies – of interventions (ROBINS-I) assessment tool. All studies showed improvement of SUI in Er:YAG laser therapy, subjectively; however, they were still inconsistent objectively. Meanwhile, based on data on sexual function, both lasers showed little improvement and were not statistically significant (p = 0.066).
Conclusion: Current evidence shows Er:YAG laser has a superior effect to sham laser in SUI patients subjectively. On the contrary, there is only a little evidence comparing Er:YAG laser with both conservative and surgical management of SUI.
Bozkurt M, Yumru AE, Şahin L. Pelvic floor dysfunction, and effects of pregnancy and mode of delivery on pelvic floor. Taiwan J Obstet Gynecol 2014;53(4):452–458. DOI: 10.1016/j.tjog.2014.08.001.
Wang H, Lau HH, Hung MJ, et al. Validation of a Mandarin Chinese version of the pelvic organ prolapse/urinary incontinence sexual questionnaire IUGA-revised (PISQ-IR). Int Urogynecol J 2015;26(11):1695–1700. DOI: 10.1007/s00192-015-2744-3.
Luber KM. The definition, prevalence, and risk factors for stress urinary incontinence. Rev Urol 2004;6(Suppl. 3):S3–S9. PMID: 16985863.
Dumoulin C, Cacciari LP, Hay–Smith EJC. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev 2018;10(10):CD005654. DOI: 10.1002/14651858.CD005654.pub4.
Ford AA, Rogerson L, Cody JD, et al. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev 2015:(7):CD006375. DOI: 10.1002/14651858.CD006375.pub3.
Dams SD, de Liefde–van Beest M, Nuijs AM, et al. Pulsed heat shocks enhance procollagen type I and procollagen type III expression in human dermal fibroblasts. Skin Res Technol 2010;16(3):354–364. DOI: 10.1111/j.1600-0846.2010.00441.x.
Lapii GA, Yakovleva AY, Neimark AI. Structural reorganization of the vaginal mucosa in stress urinary incontinence under conditions of Er:YAG laser treatment. Bull Exp Biol Med 2017;162(4):510–514. DOI: 10.1007/s10517-017-3650-0.
Ivan F, Stefica FG, Nikola F. Minimally invasive laser procedure for early stages of stress urinary incontinence (SUI). Fotona 2020;2012(1):67–74. Online ISSN: 1855–9921.
Fistonić N, Fistonić I, Guštek ŠF, et al. Minimally invasive, non-ablative Er:YAG laser treatment of stress urinary incontinence in women: A pilot study. Lasers Med Sci 2016;31(4):635–643. DOI: 10.1007/s10103-016-1884-0.
Tien Y-W, Hsiao SM, Lee CN, et al. Effects of laser procedure for female urodynamic stress incontinence on pad weight, urodynamics, and sexual function. Int Urogynecol J 2017;28(3):469–476. DOI: 10.1007/s00192-016-3129-y.
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration. BMJ 2009;339:b2700. DOI: 10.1136/bmj.b2700.
Cochrane Methods Bias. ROBINS-I. Risk of bias in non-randomized studies – of interventions (ROBINS-I). Available at: https://methods.cochrane.org/bias/risk-bias-non-randomized-studies-interventions. Accessed on: 20 Dec 2022.
Cochrane Methods Bias. RoB 2: A revised Cochrane risk-of-bias tool for randomized trials. Available at: https://methods.cochrane.org/bias/resources/rob-2-revised-cochrane-risk-bias-tool-randomized-trials. Accessed on: 20 Dec 2022.
Okui N. Comparison between erbium-doped yttrium aluminum garnet laser therapy and sling procedures in the treatment of stress and mixed urinary incontinence. World J Urol 2019;37(5):885–889.
Blaganje M, Šćepanović D, Žgur L, et al. Non-ablative Er:YAG laser therapy effect on stress urinary incontinence related to quality of life and sexual function: A randomized controlled trial. Eur J Obstet Gynecol Reprod Biol 2018;224:153–158. DOI: 10.1016/j.ejogrb.2018.03.038.
Lin HY, Tsai HW, Tsui KH, et al. The short-term outcome of laser in the management of female pelvic floor disorders: Focus on stress urine incontinence and sexual dysfunction. Taiwan J Obstet Gynecol 2018;57(6):825–829. DOI: 10.1016/j.tjog.2018.10.010.
Lin KL, Chou SH, Long CY. Effect of Er:YAG laser for women with stress urinary incontinence. BioMed Res Int 2019;2019(1):7915813. DOI: 10.1155/2019/7915813.
Pergialiotis V, Prodromidou A, Perrea DN, et al. A systematic review on vaginal laser therapy for treating stress urinary incontinence: Do we have enough evidence? Int Urogynecol J 2017;28(10):1445–1451. DOI: 10.1007/s00192-017-3437-x.
